BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29679936)

  • 1. Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey.
    Bonotto M; Basile D; Gerratana L; Pelizzari G; Bartoletti M; Vitale MG; Fanotto V; Lisanti C; Mansutti M; Minisini AM; Aprile G; De Laurentiis M; Montemurro F; Del Mastro L; Puglisi F
    Breast; 2018 Aug; 40():45-52. PubMed ID: 29679936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast Cancer.
    Seah DS; Scott S; Guo H; Najita J; Lederman R; Frank E; Sohl J; Stadler Z; Silverman S; Peppercorn J; Winer E; Come S; Lin NU
    Oncologist; 2015 Sep; 20(9):992-1000. PubMed ID: 26240134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.
    Kurian AW; Bondarenko I; Jagsi R; Friese CR; McLeod MC; Hawley ST; Hamilton AS; Ward KC; Hofer TP; Katz SJ
    J Natl Cancer Inst; 2018 May; 110(5):493-500. PubMed ID: 29237009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologists' opinions towards recommending exercise to patients with cancer: a Canadian national survey.
    Jones LW; Courneya KS; Peddle C; Mackey JR
    Support Care Cancer; 2005 Nov; 13(11):929-37. PubMed ID: 15809835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient surveillance after initial breast cancer therapy: variation by physician specialty.
    Parmeshwar R; Margenthaler JA; Allam E; Chen L; Virgo KS; Johnson FE
    Am J Surg; 2013 Aug; 206(2):218-22. PubMed ID: 23870392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
    Lambertini M; Ferreira AR; Di Meglio A; Poggio F; Puglisi F; Sottotetti F; Montemurro F; Poletto E; Bernardo A; Risi E; Dellepiane C; Sini V; Minuti G; Grasso D; Fancelli S; Del Mastro L
    Clin Breast Cancer; 2017 Dec; 17(8):601-610.e2. PubMed ID: 28479052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists.
    Karapetis CS; Guccione L; Tattersall MH; Gooden H; Vajdic CM; Lambert S; Robotin M; Mileshkin L; Schofield P
    Intern Med J; 2017 Apr; 47(4):408-414. PubMed ID: 28101916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical Oncologists' Beliefs, Practices, and Knowledge Regarding Marijuana Used Therapeutically: A Nationally Representative Survey Study.
    Braun IM; Wright A; Peteet J; Meyer FL; Yuppa DP; Bolcic-Jankovic D; LeBlanc J; Chang Y; Yu L; Nayak MM; Tulsky JA; Suzuki J; Nabati L; Campbell EG
    J Clin Oncol; 2018 Jul; 36(19):1957-1962. PubMed ID: 29746226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in treatment and care in metastatic breast cancer (MBC): are there MBC patients who are curable?
    Hattori M; Iwata H
    Chin Clin Oncol; 2018 Jun; 7(3):23. PubMed ID: 29860850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of cancer surveillance practices among medical oncologists in Washington and Oregon.
    Richert-Boe KE
    Cancer; 1995 May; 75(10):2605-12. PubMed ID: 7736408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversial issues in early-stage breast cancer: a global collaborative survey, supported by the European Society for Medical Oncology (ESMO).
    Zardavas D; Ades F; Spasojevic IB; Pugliano L; Capelan M; Paesmans M; de Azambuja E; Piccart M
    Ann Oncol; 2014 Aug; 25(8):1558-62. PubMed ID: 24562450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment recommendations for older women with breast cancer: A survey among surgical, radiation and medical oncologists.
    Hamelinck VC; Stiggelbout AM; van de Velde CJH; Liefers GJ; Bastiaannet E
    Eur J Surg Oncol; 2017 Jul; 43(7):1288-1296. PubMed ID: 28258786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate use for the management of breast cancer patients with bone metastases: a survey of Canadian Medical Oncologists.
    Verma S; Kerr-Cresswell D; Dranitsaris G; Charbonneau F; Trudeau M; Yogendran G; Cesta AM; Clemons M
    Support Care Cancer; 2004 Dec; 12(12):852-8. PubMed ID: 15322969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer.
    Lin NU; Thomssen C; Cardoso F; Cameron D; Cufer T; Fallowfield L; Francis PA; Kyriakides S; Pagani O; Senkus E; Costa A; Winer EP;
    Breast; 2013 Jun; 22(3):203-10. PubMed ID: 23601761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME).
    Pérol D; Robain M; Arveux P; Mathoulin-Pélissier S; Chamorey E; Asselain B; Berchery D; Gourgou S; Breton M; Delaine-Clisant S; Mons M; Diéras V; Carton M; Guizard AV; Laborde L; Laurent C; Loeb A; Mouret-Reynier MA; Parent D; Perrocheau G; Campion L; Velten M; Cailliot C; Ezzalfani M; Simon G
    BMJ Open; 2019 Feb; 9(2):e023568. PubMed ID: 30796119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in metastatic workup for patients with invasive breast cancer.
    Chagpar A; Babiera G; Aguirre J; Caropreso P; Hughes T;
    Am J Surg; 2015 Dec; 210(6):1147-54.e2; discussion 1153-4. PubMed ID: 26518161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How American oncologists treat breast cancer: an assessment of the influence of clinical trials.
    Belanger D; Moore M; Tannock I
    J Clin Oncol; 1991 Jan; 9(1):7-16. PubMed ID: 1985172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment choices for patients with invasive lobular breast cancer: a doctor survey.
    Jacobs C; Ibrahim MF; Clemons M; Hutton B; Simos D; Caudrelier JM; Graham ID; Smith S; Addison C; Arnaout A
    J Eval Clin Pract; 2015 Aug; 21(4):740-8. PubMed ID: 26059404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer.
    Hurvitz SA; Lalla D; Crosby RD; Mathias SD
    Breast Cancer Res Treat; 2013 Dec; 142(3):603-9. PubMed ID: 24218050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian oncologists and clinical practice guidelines: a national survey of attitudes and reported use. Provincial Lung Disease Site Group of Cancer Care Ontario.
    Graham ID; Evans WK; Logan D; O'Connor A; Palda V; McAuley L; Brouwers M; Harrison MB
    Oncology; 2000 Nov; 59(4):283-90. PubMed ID: 11096339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.